title: The Respimat Soft Mist Inhaler, a Novel Inhaled Drug Delivery Device.
abstract: Summary The Respimat SMI offers a novel delivery mechanism for the management of primarily COPD, but asthma as well. Presently, four different medications, as monotherapy or a combination of two active ingredients, are available using the Respimat SMI technology. Multiple studies have demonstrated safety and efficacy of these drugs when delivered via Respimat SMI. Patients tend to prefer the Respimat SMI over traditional inhaler devices, as it overcomes some of the disadvantages posed by traditional delivery devices.
authors: Emily A
authors: EA
authors: Perriello
authors: Diana M
authors: DM
authors: Sobieraj
mesh_terms: D000068600:Albuterol, Ipratropium Drug Combination / Q000008:administration & dosage; D001249:Asthma / Q000188:drug therapy*; D048588:Benzoxazines / Q000008:administration & dosage; D001993:Bronchodilator Agents / Q000008:administration & dosage*; D004338:Drug Combinations; D004867:Equipment Design; D006801:Humans; D009330:Nebulizers and Vaporizers; D057240:Patient Preference; D029424:Pulmonary Disease, Chronic Obstructive / Q000188:drug therapy*; D000069447:Tiotropium Bromide / Q000008:administration & dosage
chemical_list: D000068600:Albuterol, Ipratropium Drug Combination; D048588:Benzoxazines; D001993:Bronchodilator Agents; D004338:Drug Combinations; C549647:olodaterol; D000069447:Tiotropium Bromide